ARCHIVES

NeoPharm To Begin Phase III Trial For Glioblastoma

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

March 28, 1980

Sanofi Responds to Criticism From Oncologists

November 8, 2012

Ethics rules slammed by NIH scientists, institute directors, societies, Senators.

April 8, 2005

ASCO Releases Three Guidelines For Cancer Survivorship Care

April 25, 2014

ASCO Releases Guideline On Larynx Preservation

July 28, 2006

Shared Specimen Resource Needed, GYN Review Finds.

February 1, 2002